Milnacipran hydrochloride
Milnacipran hydrochloride
Milnacipran hydrochloride (pronunciation: mil-na-ci-pran hy-dro-chlor-ide) is a medication used primarily in the clinical treatment of fibromyalgia. It is a serotonin-norepinephrine reuptake inhibitor (SNRI) and is also used off-label for the treatment of major depressive disorder.
Etymology
The term "Milnacipran" is derived from the chemical structure of the drug, which is a phenylpropylamine derivative. The "hydrochloride" part of the name refers to the hydrochloride salt form in which the drug is commonly administered.
Pharmacology
Milnacipran hydrochloride works by inhibiting the reuptake of serotonin and norepinephrine, two neurotransmitters in the brain. This increases the amount of these neurotransmitters in the synaptic cleft, which can help to alleviate symptoms of fibromyalgia and depression.
Related Terms
- Fibromyalgia
- Serotonin-norepinephrine reuptake inhibitor
- Serotonin
- Norepinephrine
- Major depressive disorder
See Also
External links
- Medical encyclopedia article on Milnacipran hydrochloride
- Wikipedia's article - Milnacipran hydrochloride
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski